2004
DOI: 10.1016/j.lungcan.2003.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Results of superior vena cava resection for lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
54
0
9

Year Published

2006
2006
2017
2017

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(65 citation statements)
references
References 14 publications
2
54
0
9
Order By: Relevance
“…A variety of materials, such as autologous or bovine jugular vein, Dacron and PTFE, have been reported to be used in reconstruction of vessels, which caused lots of debate (18). Grafts made by autologous or bovine jugular vein have produced encouraging clinical results in SVC reconstruction, but without support, pericardial grafts would develop stenosis (19,20).…”
Section: Discussionmentioning
confidence: 99%
“…A variety of materials, such as autologous or bovine jugular vein, Dacron and PTFE, have been reported to be used in reconstruction of vessels, which caused lots of debate (18). Grafts made by autologous or bovine jugular vein have produced encouraging clinical results in SVC reconstruction, but without support, pericardial grafts would develop stenosis (19,20).…”
Section: Discussionmentioning
confidence: 99%
“…5,7) On the other hand, Suzuki, et al found a significant difference in survival between patients with superior vena cava invasion by metastatic lymph nodes as compared to direct tumor extension, 8) whereas others have noted that patients with pN0 status had a good prognosis. 9) In the present study, some c/cyN0 or pN0 status patients were long-term survivors after combined resection of a great vessel, while outcome was poor in patients with c/cyN1-2 or pN1-2 status or those with lymph node invasion to a great vessel.…”
Section: Discussionmentioning
confidence: 99%
“…un puente veno-venoso 4,5 , alternativa viable para un número reducido de pacientes con compromiso neoplásico de la vena cava superior (VCS) [6][7][8] . En los últimos años se ha desarrollado la cirugía endovascular, como una alternativa mínimamente invasiva, efectiva y de baja morbilidad, en especial en pacientes con etiología neoplásica [9][10][11][12][13][14][15][16][17][18] .…”
Section: N V E S T I G a C I ó Nunclassified
“…embargo, en casos de etiología maligna, la morbilidad y la mortalidad de la cirugía varían entre 23-39% y 12-14%, respectivamente, lo que parece desproporcionado en un paciente cuya mediana de sobrevida es de 9 meses [6][7][8] . En todo caso, esta opción permanece disponible luego del tratamiento endovascular y un eventual fracaso de éste.…”
Section: N V E S T I G a C I ó Nunclassified